264 related articles for article (PubMed ID: 36651922)
1. Pharmacological modulation of conditioned fear in the fear-potentiated startle test: a systematic review and meta-analysis of animal studies.
Groenink L; Verdouw PM; Zhao Y; Ter Heegde F; Wever KE; Bijlsma EY
Psychopharmacology (Berl); 2023 Nov; 240(11):2361-2401. PubMed ID: 36651922
[TBL] [Abstract][Full Text] [Related]
2. Activation of somatodendritic 5-HT
Zhao Y; Bijlsma EY; Ter Heegde F; Verdouw MP; Garssen J; Newman-Tancredi A; Groenink L
Psychopharmacology (Berl); 2019 Apr; 236(4):1171-1185. PubMed ID: 30539269
[TBL] [Abstract][Full Text] [Related]
3. Contextual fear conditioning and baseline startle responses in the rat fear-potentiated startle test: a comparison of benzodiazepine/gamma-aminobutyric acid-A receptor agonists.
Guscott MR; Cook GP; Bristow LJ
Behav Pharmacol; 2000 Sep; 11(6):495-504. PubMed ID: 11103915
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological analysis of fear-potentiated startle.
Davis M
Braz J Med Biol Res; 1993 Mar; 26(3):235-60. PubMed ID: 8257926
[TBL] [Abstract][Full Text] [Related]
5. Effects of oxytocin on background anxiety in rats with high or low baseline startle.
Ayers L; Agostini A; Schulkin J; Rosen JB
Psychopharmacology (Berl); 2016 Jun; 233(11):2165-2172. PubMed ID: 27004789
[TBL] [Abstract][Full Text] [Related]
6. Reduction of fear-potentiated startle by benzodiazepines in C57BL/6J mice.
Smith KS; Meloni EG; Myers KM; Van't Veer A; Carlezon WA; Rudolph U
Psychopharmacology (Berl); 2011 Feb; 213(4):697-706. PubMed ID: 20922362
[TBL] [Abstract][Full Text] [Related]
7. Validating a human model for anxiety using startle potentiated by cue and context: the effects of alprazolam, pregabalin, and diphenhydramine.
Baas JM; Mol N; Kenemans JL; Prinssen EP; Niklson I; Xia-Chen C; Broeyer F; van Gerven J
Psychopharmacology (Berl); 2009 Jul; 205(1):73-84. PubMed ID: 19415242
[TBL] [Abstract][Full Text] [Related]
8. No effect of sex and estrous cycle on the fear potentiated startle response in rats.
Zhao Y; Bijlsma EY; Verdouw MP; Groenink L
Behav Brain Res; 2018 Oct; 351():24-33. PubMed ID: 29803653
[TBL] [Abstract][Full Text] [Related]
9. Antagonists at the serotonin-3 receptor can reduce the fear-potentiated startle response in the rat: evidence for different types of anxiolytic activity?
Nevins ME; Anthony EW
J Pharmacol Exp Ther; 1994 Jan; 268(1):248-54. PubMed ID: 7905528
[TBL] [Abstract][Full Text] [Related]
10. Favoured genetic background for testing anxiolytics in the fear-potentiated and light-enhanced startle paradigms in the rat.
Steiner MA; Lecourt H; Rakotoariniaina A; Jenck F
Behav Brain Res; 2011 Aug; 221(1):34-42. PubMed ID: 21354212
[TBL] [Abstract][Full Text] [Related]
11. Benzodiazepines have no effect on fear-potentiated startle in humans.
Baas JM; Grillon C; Böcker KB; Brack AA; Morgan CA; Kenemans JL; Verbaten MN
Psychopharmacology (Berl); 2002 May; 161(3):233-47. PubMed ID: 12021826
[TBL] [Abstract][Full Text] [Related]
12. The contribution of contextual fear in the anxiolytic effect of chlordiazepoxide in the fear-potentiated startle test.
Zhao Y; Bijlsma EY; Verdouw PM; Garssen J; Groenink L
Behav Brain Res; 2018 Nov; 353():57-61. PubMed ID: 29969605
[TBL] [Abstract][Full Text] [Related]
13. Distinct contributions of median raphe nucleus to contextual fear conditioning and fear-potentiated startle.
Silva RC; Cruz AP; Avanzi V; Landeira-Fernandez J; Brandão ML
Neural Plast; 2002; 9(4):233-47. PubMed ID: 12959153
[TBL] [Abstract][Full Text] [Related]
14. Control conditions in the fear-potentiated startle response paradigm.
Joordens RJ; Hijzen TH; Peeters BW; Olivier B
Neuroreport; 1997 Mar; 8(4):1031-4. PubMed ID: 9141086
[TBL] [Abstract][Full Text] [Related]
15. Acute escitalopram but not contextual conditioning exerts a stronger "anxiogenic" effect in rats with high baseline "anxiety" in the acoustic startle paradigm.
Pettersson R; Näslund J; Nilsson S; Eriksson E; Hagsäter SM
Psychopharmacology (Berl); 2015 Apr; 232(8):1461-9. PubMed ID: 25417552
[TBL] [Abstract][Full Text] [Related]
16. The brain orexin system and almorexant in fear-conditioned startle reactions in the rat.
Steiner MA; Lecourt H; Jenck F
Psychopharmacology (Berl); 2012 Oct; 223(4):465-75. PubMed ID: 22592903
[TBL] [Abstract][Full Text] [Related]
17. Anxiolytic effects of buspirone and gepirone in the fear-potentiated startle paradigm.
Kehne JH; Cassella JV; Davis M
Psychopharmacology (Berl); 1988; 94(1):8-13. PubMed ID: 2894703
[TBL] [Abstract][Full Text] [Related]
18. Serotonin does not mediate anxiolytic effects of buspirone in the fear-potentiated startle paradigm: comparison with 8-OH-DPAT and ipsapirone.
Davis M; Cassella JV; Kehne JH
Psychopharmacology (Berl); 1988; 94(1):14-20. PubMed ID: 2894698
[TBL] [Abstract][Full Text] [Related]
19. The GABA(B) receptor positive modulator BHF177 attenuated anxiety, but not conditioned fear, in rats.
Li X; Kaczanowska K; Finn MG; Markou A; Risbrough VB
Neuropharmacology; 2015 Oct; 97():357-64. PubMed ID: 26002628
[TBL] [Abstract][Full Text] [Related]
20. The benzodiazepine alprazolam dissociates contextual fear from cued fear in humans as assessed by fear-potentiated startle.
Grillon C; Baas JM; Pine DS; Lissek S; Lawley M; Ellis V; Levine J
Biol Psychiatry; 2006 Oct; 60(7):760-6. PubMed ID: 16631127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
